West Pharmaceutical Services, Inc. logo
WSTWest Pharmaceutical Services, Inc.

FCF Payout Ratio: 13.49%

popular:market cap|pe ratio|revenue|price history|total return

Is the FCF payout ratio high or low?

The FCF payout ratio of 13.49% is 12% below its 5-year average of 15.28%, near the low end of its 5-year range (12.31%–21.38%).

15.08% below its 12-month average of 15.89%.

Dividends Overview|Dividends per Share|Dividends CAGR|Payout Ratio|Dividend Yield
FCF Payout Ratio

WST FCF Payout Ratio

13.49%

Rolling trailing-12-month FCF payout ratio sampled each quarter; raw quarterly payout is intentionally not charted.

-21.97% 5Y
WST FCF Payout Ratio

WST Average FCF Payout Ratio Chart

WST FCF Payout Ratio

WST Current vs Average FCF Payout Ratio Chart

WST FCF Payout Ratio Metrics

FCF PAYOUT RATIO

13.49%

FCF PAYOUT RATIO AVG TTM

15.89%

FCF PAYOUT RATIO AVG 3Y

15.76%

FCF PAYOUT RATIO AVG 5Y

14.98%

FCF PAYOUT RATIO AVG 10Y

17.51%

FCF PAYOUT RATIO AVG 15Y

28.67%

FCF PAYOUT RATIO AVG 20Y

30.26%

CURRENT VS TTM AVG

-15.08%

CURRENT VS 3Y AVG

-14.36%

CURRENT VS 5Y AVG

-9.92%

CURRENT VS 10Y AVG

-22.96%

CURRENT VS 15Y AVG

-52.93%

CURRENT VS 20Y AVG

-55.41%

Payout Ratio Comparison

FCF Payout Ratio TTM

13.5%

Earnings Payout Ratio

12.9%

Dividend Yield

0.25%

FCF Yield

1.80%

Annual FCF Payout Ratio History

YearFree Cash FlowDividends PaidFCF Payout Ratio
2025$468.90M$61.20M13.1%
2024$276.40M$59.10M21.4%
2023$414.50M$57.00M13.8%
2022$439.40M$54.10M12.3%
2021$330.60M$51.10M15.5%
2020$298.10M$48.10M16.1%
2019$240.80M$45.10M18.7%
2018$183.90M$42.10M22.9%
2017$132.50M$39.10M29.5%
2016$49.20M$35.80M72.8%
2015$80.80M$32.40M40.1%
2014$70.80M$29.10M41.1%
2013$64.70M$26.80M41.4%
2012$55.40M$24.90M44.9%
2011$33.90M$23.20M68.4%
2010$64.50M$21.70M33.6%
2009$29.90M$20.10M67.2%
2008($4.10M)$18.60MN/A (Loss)
2007($0.20M)$17.50MN/A (Loss)
2006$53.50M$15.90M29.7%
2005$31.50M$14.10M44.8%
2004$11.50M$12.80M111.3%
2003$8.40M$11.80M140.5%
2002$16.20M$11.10M68.5%
2001($11.40M)$10.50MN/A (Loss)
2000($8.70M)$9.80MN/A (Loss)
1999$6.00M$10.30M171.7%
1998($5.70M)$9.40MN/A (Loss)
1997$33.30M$9.40M28.2%
1996$31.70M$10.00M31.5%

Formula: FCF Payout Ratio TTM = trailing 4Q dividends paid / trailing 4Q free cash flow × 100

FCF payout and earnings payout:

  • FCF represents operating cash flow after capital expenditures
  • FCF payout compares dividends paid with free cash flow
  • FCF payout above 100% means dividends paid exceeded free cash flow for the period
  • Earnings payout compares dividends paid with net income

Reading the series: Use the chart and table to compare dividend payments with cash generation over time.

FCF Payout Ratio Formula & Definition

FCF Payout Ratio measures trailing dividends paid as a percentage of trailing free cash flow. Unlike earnings-based payout, it compares dividends with cash generated after capital expenditures.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

FCF Payout Ratio FAQ

What is the FCF payout ratio for West Pharmaceutical Services, Inc. (WST)?
The FCF payout ratio for WST stock is 13.49%.
Is West Pharmaceutical Services, Inc.'s FCF payout ratio high or low?
The FCF payout ratio of 13.49% is 12% below its 5-year average of 15.28%, near the low end of its 5-year range (12.31%–21.38%).
What is the TTM average FCF payout ratio for West Pharmaceutical Services, Inc. (WST)?
The TTM average FCF payout ratio for WST stock is 15.89%.
What is the 3Y average FCF payout ratio for West Pharmaceutical Services, Inc. (WST)?
The 3Y average FCF payout ratio for WST stock is 15.76%.
What is the 5Y average FCF payout ratio for West Pharmaceutical Services, Inc. (WST)?
The 5Y average FCF payout ratio for WST stock is 14.98%.
What is the 10Y average FCF payout ratio for West Pharmaceutical Services, Inc. (WST)?
The 10Y average FCF payout ratio for WST stock is 17.51%.
What is the 15Y average FCF payout ratio for West Pharmaceutical Services, Inc. (WST)?
The 15Y average FCF payout ratio for WST stock is 28.67%.
What is the 20Y average FCF payout ratio for West Pharmaceutical Services, Inc. (WST)?
The 20Y average FCF payout ratio for WST stock is 30.26%.

WST FCF Payout Ratio History

DATEFCF PAYOUT RATIO
2026-03-3113.49%
2025-12-3113.05%
2025-09-3016.01%
2025-06-3017.47%
2025-03-3119.42%
2024-12-3121.38%
2024-09-3018.22%
2024-06-3016.27%
2024-03-3114.92%
2023-12-3113.75%
2023-09-3013.40%
2023-06-3014.06%
2023-03-3113.37%
2022-12-3112.31%
2022-09-3013.74%
2022-06-3013.05%
2022-03-3113.59%
2021-12-3115.46%
2021-09-3014.78%
2021-06-3017.29%
2021-03-3115.92%
2020-12-3116.14%
2020-09-3017.38%
2020-06-3016.76%
2020-03-3118.54%
2019-12-3118.73%
2019-09-3020.63%
2019-06-3021.72%
2019-03-3123.05%
2018-12-3122.89%
2018-09-3021.48%
2018-06-3023.62%
2018-03-3124.05%
2017-12-3129.51%
2017-09-3036.55%
2017-06-3045.06%
2017-03-3153.51%
2016-12-3172.76%
2016-09-3072.56%
2016-06-3050.52%
2016-03-3143.06%
2015-12-3140.10%
2015-09-3041.42%
2015-06-3042.48%
2015-03-3148.70%
2014-12-3141.10%
2014-09-3036.19%
2014-06-3041.55%
2014-03-3132.12%
2013-12-3141.42%
2013-09-3034.97%
2013-06-3035.10%
2013-03-3182.95%
2012-12-3144.95%
2012-09-3094.57%
2012-06-30123.71%
2012-03-3193.36%
2011-12-3168.44%
2011-09-3045.42%
2011-06-3034.46%
2011-03-3136.09%
2010-12-3133.64%
2010-09-3032.67%
2010-06-3045.43%
2010-03-3137.99%
2009-12-3167.22%
2007-06-30100.00%
2007-03-3147.95%
2006-12-3129.72%
2006-09-3026.83%
2006-06-3030.63%
2006-03-3141.24%
2005-12-3144.76%
2005-09-3037.23%
2005-06-3046.37%
2005-03-3196.30%
2004-12-31111.30%
2003-12-31140.48%
2003-09-3063.74%
2003-06-3048.10%
2003-03-3142.11%

Related Metrics

Dividends OverviewDividends per ShareDividends CAGRPayout RatioDividend Yield

About West Pharmaceutical Services, Inc.

West Pharmaceutical Services, Inc. (WST) specializes in the development, manufacturing, and global distribution of essential containment and delivery solutions for injectable pharmaceuticals and other healthcare products. The company's operations span across the Americas, Europe, the Middle East, Africa, and the Asia Pacific region, structured into two primary business units: Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers a comprehensive array of components for injectable packaging, including stoppers and seals, alongside syringe and cartridge parts, which can be customized for specific injectable drug delivery requirements. It also provides advanced drug administration systems designed to enhance safe and effective delivery through sophisticated reconstitution, mixing, and transfer technologies. This segment further supplies ancillary services such as specialized films, protective coatings, cleaning, precision vision inspection, and sterilization processes to elevate the quality of packaging components. Innovative drug containment options, like Crystal Zenith – a cyclic olefin polymer used in vials, syringes, and cartridges – and user-friendly self-injection devices are also key offerings. Additionally, it provides a suite of integrated support services covering analytical laboratory analysis, primary packaging assistance during the pre-approval stage, engineering development, regulatory guidance, and post-purchase technical support. Its clientele primarily includes manufacturers of biologic, generic, and other pharmaceutical products. In contrast, the Contract-Manufactured Products division focuses on the design, production, and automated assembly of various devices for surgical, diagnostic, ophthalmic, and general drug delivery applications, alongside consumer items. This segment caters to pharmaceutical, diagnostic, and medical device manufacturers. The company's offerings reach customers worldwide through a dedicated sales team, an extensive distribution network, and partnerships with contract sales agents and regional distributors. Established in 1923, West Pharmaceutical Services, Inc. is headquartered in Exton, Pennsylvania.

Exton, PA
10,600 employees
www.westpharma.com
Healthcare / Medical - Instruments & Supplies
Sector
Healthcare
Industry
Medical - Instruments & Supplies
CEO
Eric Green
View full financials